PT - JOURNAL ARTICLE AU - Fan, F S Y AU - Chow, K M AU - Szeto, C C AU - Li, P K T TI - Hyperchloraemic metabolic acidosis AID - 10.1136/emj.2008.059923 DP - 2008 Sep 01 TA - Emergency Medicine Journal PG - 613--613 VI - 25 IP - 9 4099 - http://emj.bmj.com/content/25/9/613.short 4100 - http://emj.bmj.com/content/25/9/613.full SO - Emerg Med J2008 Sep 01; 25 AB - Cholestyramine carries a risk of hyperchloraemic metabolic acidosis. Being cognisant of this drug-induced adverse event may reduce diagnostic delays. Emergency physicians should be alert about this condition, in particular among patients with pre-existing chronic kidney disease, or who are taking spironolactone.